Free Trial
ASX:AVN

Aventus Group (AVN) Stock Price, News & Analysis

Aventus Group logo

About Aventus Group Stock (ASX:AVN)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
1.17 million shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
5.50%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Aventus Group is Australia's largest fully-integrated owner, manager and developer of large format retail centres in Australia with a portfolio of 20 centres valued at $2.2 billion. Aventus Group portfolio spans 536,000m2 in gross leasable area and features a diverse tenant base of 593 quality tenancies, with national tenants representing 87 per cent of the total portfolio. Our team of more than 70 professionals offer expertise in investment management, asset management and corporate services, delivering operational excellence and value at every stage of the investment cycle. Our single-sector focus has allowed Aventus to achieve sustainable income growth since the Fund was listed in October 2015, with consistently high occupancy, positive leasing spreads and low incentives across the portfolio.

Receive AVN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aventus Group and its competitors with MarketBeat's FREE daily newsletter.

AVN Stock News Headlines

Here’s How to Claim Your Stake in Elon’s Private Company, xAI
I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.
Aventus Law Group Offers New Hope for Taxpayers Facing IRS Disputes
Where I would invest my Fortescue dividends
See More Headlines

AVN Stock Analysis - Frequently Asked Questions

Aventus Group (ASX:AVN) issued its quarterly earnings data on Thursday, February, 14th. The company reported $0.09 earnings per share for the quarter, missing analysts' consensus estimates of $0.09 by $0.00.

Based on aggregate information from My MarketBeat watchlists, some other companies that Aventus Group investors own include Milestone Pharmaceuticals (MIST), Ovintiv (OVV), SIG (SHI), Allena Pharmaceuticals (ALNA), Alpine Immune Sciences (ALPN), Affiliated Managers Group (AMG) and Aravive (ARAV).

Company Calendar

Last Earnings
2/14/2019
Today
5/13/2025

Industry, Sector and Symbol

Stock Exchange
ASX
Industry
REIT - Retail
Sub-Industry
N/A
Current Symbol
ASX:AVN
CIK
N/A
Fax
N/A
Employees
147,000
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
3.81
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$182.80 million
Price / Cash Flow
104.71
Book Value
A$3.35 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (ASX:AVN) was last updated on 5/13/2025 by MarketBeat.com Staff
From Our Partners